5.13 Brevetto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.354
EU - Europa 6.783
AS - Asia 5.048
SA - Sud America 539
AF - Africa 100
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 1
Totale 20.847
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.255
IT - Italia 1.778
CN - Cina 1.448
RU - Federazione Russa 1.331
SG - Singapore 1.212
SE - Svezia 1.118
IE - Irlanda 750
KR - Corea 679
TR - Turchia 533
DE - Germania 471
BR - Brasile 412
UA - Ucraina 385
VN - Vietnam 378
GB - Regno Unito 301
HK - Hong Kong 300
FR - Francia 176
FI - Finlandia 160
IN - India 128
CH - Svizzera 114
BD - Bangladesh 86
AT - Austria 56
IQ - Iraq 47
CA - Canada 45
PK - Pakistan 38
AR - Argentina 35
MX - Messico 33
ZA - Sudafrica 31
SA - Arabia Saudita 30
NL - Olanda 29
ID - Indonesia 27
VE - Venezuela 25
PL - Polonia 23
AL - Albania 22
UZ - Uzbekistan 22
AE - Emirati Arabi Uniti 21
CO - Colombia 21
ES - Italia 21
EU - Europa 21
JP - Giappone 18
BE - Belgio 17
MY - Malesia 17
EC - Ecuador 16
TN - Tunisia 15
MA - Marocco 14
PH - Filippine 12
LT - Lituania 10
EG - Egitto 9
PE - Perù 9
CL - Cile 7
DZ - Algeria 7
ET - Etiopia 7
IL - Israele 7
JO - Giordania 6
PY - Paraguay 6
AZ - Azerbaigian 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
NP - Nepal 4
BG - Bulgaria 3
BO - Bolivia 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
JM - Giamaica 3
KG - Kirghizistan 3
SN - Senegal 3
TH - Thailandia 3
AM - Armenia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HU - Ungheria 2
IR - Iran 2
KE - Kenya 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
LY - Libia 2
ME - Montenegro 2
OM - Oman 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
AU - Australia 1
BH - Bahrain 1
BJ - Benin 1
BS - Bahamas 1
BW - Botswana 1
CI - Costa d'Avorio 1
CY - Cipro 1
DJ - Gibuti 1
DM - Dominica 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
IM - Isola di Man 1
IS - Islanda 1
KH - Cambogia 1
KW - Kuwait 1
MK - Macedonia 1
Totale 20.832
Salva come PNG Salva come JPEG
Città #
Pisa 984
Jacksonville 856
Ashburn 760
Dublin 748
Chandler 747
Dallas 735
San Jose 694
Seoul 677
Singapore 467
Boardman 466
Council Bluffs 410
Izmir 396
Wilmington 359
Ann Arbor 325
Moscow 317
Beijing 302
Hong Kong 285
Hefei 251
Düsseldorf 182
Boston 178
Millbury 175
Dong Ket 144
Los Angeles 119
Milan 119
Kent 116
San Mateo 115
Istanbul 109
Lauterbourg 105
Mestre 104
The Dalles 100
Bern 92
New York 87
Seattle 87
Woodbridge 85
Dearborn 78
Bremen 76
Ho Chi Minh City 76
Lawrence 71
Ogden 65
North Bergen 62
Scuola 60
Hanoi 58
Brescia 56
Santa Clara 55
Princeton 54
Vienna 50
Buffalo 48
Chicago 47
Guangzhou 43
Saint Petersburg 43
San Giuliano Terme 39
Munich 38
Rome 35
São Paulo 34
Helsinki 33
Orem 33
Chennai 30
Shanghai 30
Florence 22
Wuhan 22
Brooklyn 21
Nanjing 21
Padova 21
Warsaw 21
London 19
Tashkent 19
Johannesburg 18
Kunming 18
Washington 18
Zurich 18
Manchester 17
Montreal 17
Toronto 17
Baghdad 16
Brussels 16
Frankfurt am Main 15
Tokyo 15
Andover 14
Jiaxing 14
Atlanta 13
Da Nang 13
Jinan 13
Lahore 13
Norwalk 13
Turku 13
Bientina 12
Dhaka 12
Mexico City 12
Phoenix 12
Poplar 12
Rio de Janeiro 12
Yiwu 12
Amsterdam 11
Cambridge 11
Denver 11
Houston 11
San Francisco 11
Stockholm 11
Ankara 10
Fairfield 10
Totale 13.537
Salva come PNG Salva come JPEG
Nome #
Liquid motion control device for Lab-on-a-Chip (LOC) system of e.g. food analysis apparatus, has control unit with acoustic resonator that reflects surface acoustic wave (SAW) when quantity of liquid is present within acoustic resonator 326
METHOD TO ANIMATE ON A COMPUTER SCREEN A VIRTUAL PEN WHICH WRITES AND DRAWS 317
METODO PER ANIMARE SULLO SCHERMO DI UN COMPUTER UNA PENNA VIRTUALE CHE SCRIVE E DISEGNA 314
METHOD TO ANIMATE ON A COMPUTER SCREEN A VIRTUAL PEN WHICH WRITES AND DRAWS 303
VECTOR FOR THE RELEASE OF AN ACTIVE AGENT WHICH IS PHOTOCLEAVABLE BY IRRADIATION IN THE VISIBLE 295
Composti particolarmente catalizzatori di poliuretani 286
Dispositivo automatizzato per la riabilitazione motoria e per la valutazione della funzionalità degli arti anteriori in modelli animali 279
Bucket brigade address decoding architecture for classical and quantum random access memories 277
METHOD TO SYNCHRONIZE AUDIO AND GRAPHICS IN A MULTIMEDIA PRESENTATION 276
COMPOSIZIONI IN GRADO DI PREVENIRE EVENTI NEURODEGENERATIVI E METODO PER SAGGIARNE L'ATTIVITA' 271
Method and device for measuring position and mass 265
Determinazione dell'organizzazione supramolecolare di molecole incapsulate tramite analisi del tempo di vita della luminescenza 264
Superfici funzionali con morfologia controllata sulla scala nanometrica atte a modulare l’adesione, vitalità e proliferazione di cellule 253
NACYLUREA COMPOUNDS FOR PREPARING POLYURETHANES 249
ANIMALI TRANSGENICI NON UMANI ANTI-NGF 244
METHOD TO SYNCHRONIZE AUDIO AND GRAPHICS IN A MULTIMEDIA PRESENTATION 241
MUTEINS OF HNGF, THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS 239
Laser circolari a semiconduttore con reticoli per emissione verticale 229
Metodo non invasivo per misurare il contenuto idrico assoluto di una foglia 222
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 207
Nanoresonator structure used as nanosensor for e.g. medical application, comprises conductive material layers and dielectric layer, and is represented by specific circuit with resonant frequency determined by geometrical dimensions 206
Use of an anti-NGF IgG4 isotype antibody for treating and/or preventing chronic pain 200
VECTOR FOR THE RELEASE OF AN ACTIVE AGENT WHICH IS PHOTOCLEAVABLE BY IRRADIATION IN THE VISIBLE 192
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 188
NOVEL ANALGESIC TREATMENT WITH PROLONGED EFFECT 186
Method for Ensuring privacy while querying a database by using quantum superpositions and multiple responses 186
Method for the humanization of antibodies and humanized antibodies thereby obtained 184
COMPOSITIONS ABLE TO PREVENT NEURODEGENERATIVE PROCESSES AND METHODS OF ASSAYING THE SAME 183
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 180
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT. 178
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 178
Method for the humanization of antibodies and humanized antibodies thereby obtained 177
INTRACELLULAR ANTIBODIES 177
Method for the humanization of antibodies and humanized antibodies thereby obtained. 175
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 174
Method for the potentiation of opioid analgesics effects on pain 172
ANIMALI TRANSGENICI NON UMANI ESPRIMENTI ANTICORPI ANTI-NGF. 172
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 171
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 168
Method for the humanization of antibodies and humanized antibodies thereby obtained. 164
Novel analgesic treatment with prolonged effect 164
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 163
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 162
Selection of intracellular immunoglobulins 162
Method of identifying a consensus sequence for intracellular antibodies 162
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 161
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 161
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 161
Method for the potentiation of opioid analgesics effects on pain 161
METODO PER IDENTIFICARE UN INIBITORE SELETTIVO DEL PRONGF E INIBITORI SELEZIONATI CON ESSO 161
Selection of intracellular immunoglobulins 161
Humanized anti-NGF antibodies 160
Non human transgenic animal as a model of neurodegenerative diseases and for the early diagnosis thereof 160
Intracellular selection 160
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 159
Humanized anti-NGF antibodies 159
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 159
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 158
Intracellular selection 158
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 157
Intracellular selection 157
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TRKA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 157
Novel analgesic treatment with prolonged effect 157
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 156
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 155
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 155
INTRACELLULAR ANTIBODIES 155
Method for the humanization of antibodies and humanized antibodies thereby obtained 154
NGF AND TrkA RECEPTOR BINDING INHIBITING MOLECULES AS PROLONGED ANALGESICS 153
Method for the humanization of antibodies and humanized antibodies thereby obtained. 153
Selection of intracellular immunoglobulins 153
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 152
SEQUENZE CONSENSO PER ANTICORPI INTRACELLULARI E LORO USO 151
Selection of intracellular immunoglobulins 151
null 150
Compositions able to prevent neurodegenerative processes and methods of assaying the same 150
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 150
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 150
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 150
TRANSGENIC MICE FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 150
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 149
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 148
Method for the humanization of antibodies and humanized antibodies thereby obtained. 148
Humanized anti-NGF antibodies 147
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 147
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 147
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 146
Non-human transgenic animals for the study of neurodegenerative syndromes 146
Method for the humanization of antibodies and humanized antibodies thereby obtained 146
Molecules that are able to inhibit the binding between NGF and the Trka receptor as analgesics with prolonged effect 146
Selection of intracellular immunoglobulins 146
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 146
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 144
Method for the potentiation of opioid analgesics effects on pain 143
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TRKA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 143
Novel analgesic treatment with prolonged effect 143
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 143
INTRACELLULAR ANTIBODIES 142
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 142
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 142
Totale 18.140
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021261 0 0 0 0 0 0 0 0 0 0 0 261
2021/2022914 120 0 22 121 15 5 10 69 50 58 19 425
2022/20233.491 239 136 136 218 159 378 0 970 1.112 22 38 83
2023/20241.167 208 48 93 31 53 120 18 118 197 22 18 241
2024/20253.236 93 34 175 168 473 14 40 188 653 151 599 648
2025/20267.522 550 665 983 692 302 319 1.117 462 979 598 564 291
Totale 21.071